| Connective Tissue Diseases |
NCT00862758: Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab |
|
|
| No Longer Available | N/A | | US | Tocilizumab | University of Oklahoma, Hoffmann-La Roche | Juvenile Idiopathic Arthritis | 10/10 | 10/10 | | |
LBRA99, NCT00931086: Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol |
|
|
| No Longer Available | N/A | | US | belimumab, BENLYSTA™ (belimumab), LymphoStat-B™ | Human Genome Sciences Inc., a GSK Company, GlaxoSmithKline | Rheumatoid Arthritis | 12/11 | 12/11 | | |
| No Longer Available | N/A | | RoW | Technetium labelled glucosamine | University of Sydney, AbbVie | Rheumatoid Arthritis, Ankylosing Spondylitis | | | | |
NCT02097251: An Open-Label Treatment Protocol With UX003 rhGUS Enzyme Replacement Therapy for an Advanced Stage MPS 7 Patient |
|
|
| No Longer Available | N/A | | US | UX003, recombinant human beta glucuronidase, rhGUS | Joyce Fox, Ultragenyx Pharmaceutical Inc | Mucopolysaccharidosis Type 7 | | | | |
NCT03125486: Compassionate Use for Subcutaneous (SC) Belimumab |
|
|
| No Longer Available | N/A | | US | SC belimumab 200 mg | GlaxoSmithKline | Systemic Lupus Erythematosus | | | | |
DAD, NCT01238276: Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion |
|
|
| No Longer Available | N/A | | US | Cefazolin, Ancef, Kefzol, Silberg Tissue Preparation System, Silberg TPS (K023083), Tissue Preparation System, TPS, Mettler ME800 | Sonescence, Inc. | Infection, Soft Tissue, Infection, Wound, Cellulitis, Diabetic Foot Ulcer | | | | |
NCT02557295: An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA |
|
|
| Terminated | N/A | 248 | NA | | Celltrion | Rheumatoid Arthritis | 03/20 | 03/20 | | |
| Recruiting | N/A | 150 | Europe | | J.M.W. Hazes, Erasmus Medical Center, Dutch Arthritis Association | Rheumatoid Arthritis, Pregnancy | 06/21 | 05/25 | | |
NCT01088360: Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) |
|
|
| Active, not recruiting | N/A | 20000 | NA | | Bristol-Myers Squibb, National Data Bank for Rheumatic Diseases (NDB) | Rheumatoid Arthritis | 06/29 | 06/29 | | |